MG
ZURA icon

Michael Gelband’s Zura Bio ZURA Stock Holding History

Michael Gelband’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,921
Closed -$246K – 2176
2025
Q4 		$246K Buy
+46,921
New +$186K ﹤0.01% 1355

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Michael Gelband's ZURA Position: Q1 2026 in Review

Michael Gelband sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 46,921 shares — an estimated $246K sold.

Michael Gelband first reported a position in ZURA in Q4 2025 and held it in 1 quarter. The position peaked at $246K in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Michael Gelband reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 46,921 Zura Bio shares in Q1 2026, an estimated $246K.
  • Michael Gelband first reported a position in Zura Bio in Q4 2025 and held it in 1 quarter.
  • Michael Gelband's Zura Bio position peaked at $246K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.